Aloha

Anter

• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO Hops ka wahi maloʻo, pua o ka mea kanu hop. Hoʻohana mau ʻia lākou i ka pia ʻana i ka pia a me nā mea ʻono i nā meaʻai. Hoʻohana ʻia ka hops e hana i ka lāʻau.

Hoʻohana pinepine ʻia nā hops no ka hopohopo, nā maʻi hiamoe e like me ka hiki ʻole o ka hiamoe (hiamoe) a i ʻole hiamoe hiamoe ma muli o ke kaʻapuni ʻana a i ʻole nā ​​hola hana i ka pō (hoʻololi i ka maʻi hana), hoʻomaha ʻole, hoʻopilikia, hauʻoli, ʻike deficit-hyperactivity maʻi (ADHD), hopohopo, huhū, a me nā ʻōuli o ka menopause i waena o nā hoʻohana ʻē aʻe. Akā he palena ʻepekema hōʻike e kākoʻo i ka hoʻohana ʻana i nā manaʻolana no kekahi o kēia mau ʻano.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no NA LOA penei:

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• E hōʻole i ka hoʻomanaʻo a me nā mākau noʻonoʻo e hana maʻamau me ka makahiki. Hōʻike ka noiʻi mua i ka lawe ʻana i nā waikawa ʻawaʻawa mai nā hops no 12 mau pule hiki ke hoʻomaikaʻi i ka noʻonoʻo noʻonoʻo a me ka luhi o ka noʻonoʻo i ka poʻe kahiko. Akā ʻaʻole ia e hoʻomaikaʻi i ka hoʻomanaʻo.
• Nā ʻōuli o ka menopause. Hōʻike ka noiʻi mua i ka lawe ʻana i kahi huahana kikoʻī i loaʻa i ka hop hops i kēlā me kēia lā ʻaʻole hoʻomaikaʻi i nā hōʻailona menopausal e like me nā uila wela ma hope o 8-12 mau pule o ka lapaʻau.
• Ka maʻi hiamoe ma muli o ke kaʻapuni ʻana a i ʻole nā ​​hoʻololi pō (hoʻololi i nā maʻi hana). Hōʻike ka noiʻi mua i ka inu ʻana i ka pia ʻona ʻole i loko o ka hop i ka ʻaina ahiahi hiki ke hōʻemi i ka nui o ka manawa e hiamoe ai ma kahi o 8 mau minuke i nā kahu hānai e hana ana a i ʻole nā ​​hoʻololi pō. Me he mea lā hoʻi e hoʻemi ana i ka hana holoʻokoʻa i ka pō a me ka hopohopo. Eia naʻe, ʻaʻole ia he mea e hoʻonui ai i ka huina nui o ka manawa i hiamoe.
• Hopohopo.
• Ka maʻi deficit-hyperactivity maʻi (ADHD).
• Pilau kino.
• Hānai umauma.
• Maʻi ʻaʻai umauma.
• Excitability.
• Nā pae kiʻekiʻe o ke kolesterol a i ʻole nā ​​momona ʻē aʻe (lipids) i ke koko (hyperlipidemia).
• Hoʻonui i ka makemake.
• Hoʻopilikia (dyspepsia).
• ʻO Insomnia.
• ʻ .pala ʻōpū.
• Huhū.
• Nā ʻeha ʻūhā i hoʻokumu ʻia e ke kahena nāwaliwali o ke koko (ulcer leg venous leg).
• ʻEha ʻeha.
• Weliweli.
• Maʻi ʻaʻai Ovarian.
• Overad bladder.
• ʻO ka ʻeha a me ka pehu ʻana (ka mumū) o ka ʻōpū.
• Maʻi ʻaʻai Prostate.
• Hoʻomaha ʻole.
• Hoʻolaha.
• Maʻi puʻu.
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ka maikaʻi o nā hop no kēia mau hoʻohana.

ʻO nā kemika i loko o nā hop e like me nā hopena nāwaliwali e like me ka estrogen estrogen. ʻO kekahi mau kemika i loko o nā hop e like me ka mea e hōʻemi ai i ka pehu ʻana, pale i nā maʻi, a hoʻomaka ka hiamoe.

Ke lawe ʻia e ka waha: Aloha oe LIKELY SAFE ke hoʻopau ʻia i nā kālā i ʻike mau ʻia i nā meaʻai. Aloha nō SAFE MAU PONO ke lawe ʻia no ka hoʻohana lāʻau, wā pōkole. Hiki i ka Hops ke hoʻoluhi a me ka hiamoe i kekahi poʻe. ʻIke paha nā wahine e lawe ana i ka hop i nā loli i kā lākou menstrual cycle.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻAʻole lawa ka ʻike hilinaʻi e ʻike ai inā palekana ka hops ke hoʻohana ʻia i ka wā hāpai a hānai umauma paha. Noho ma ka ʻaoʻao palekana a pale i ka hoʻohana.

Kaumaha: Hops e hoʻonui i ke kaumaha. Pale hoʻohana.

Nā maʻi ʻaʻai Hormone a me nā kūlana: ʻO kekahi mau kemika i nā hop e like me ka hormone estrogen. ʻO ka poʻe i loaʻa nā ʻano e makaʻala i nā hormoni e hōʻalo i nā hop. ʻO kekahi o kēia mau ʻano me ka maʻi ʻaʻai a me ka endometriosis.

ʻOki kino: Hiki i ka Hops ke hiamoe nui ke hui ʻia me ka anesthesia a me nā lāʻau ʻē aʻe i ka wā a ma hope o nā kaʻina hana. E hōʻoki i ka lawe ʻana i nā hop i ka hala ma mua o 2 mau pule ma mua o ke kaha ʻana i hoʻonohonoho ʻia.

Kānāwai

E akahele me kēia hui ʻana.

ʻAlekohola (Ethanol)

Hiki i ka waiʻona ke hana i ka hiamoe a me ka hiamoe. Hiki paha i ka Hops ke hiamoe a me ka hiamoe. ʻO ka lawe ʻana i ka nui o nā hop a me ka waiʻona paha ka mea e hiamoe nui ai.

ʻO Estrogens

Loaʻa paha iā Hops kekahi o nā hopena e like me ka estrogen. ʻO ka lawe ʻana i nā hops me nā pila estrogen hiki ke hoʻemi i nā hopena o nā pila estrogen.

ʻO kekahi o nā pila estrogen me nā conjugated equine estrogens (Premarin), ethinyl estradiol, estradiol, a me nā mea ʻē aʻe.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 1A1 (CYP1A1) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E loli paha ka hops i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. Lawe i ka hops me kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa e hoʻonui a hoʻemi paha i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau. Ma mua o ka lawe ʻana i nā hop, e kamaʻilio me kāu kauka inā ʻoe e lawe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi o kēia mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi ʻo chlorzoxazone, theophylline, a me bufuralol.

Ua hoʻololi ʻia nā lāʻau e ke ake (Cytochrome P450 1A2 (CYP1A2) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. Hiki i nā hops ke hoʻēmi i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. Lawe i ka hops me kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa e hoʻonui paha i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau. Ma mua o ka lawe ʻana i nā hop, e kamaʻilio me kāu kauka inā ʻoe e lawe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi o kēia mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi ʻo clozapine (Clozaril), cyclobenzaprine (Flexeril), fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), olanzapine (Zyprexa), pentazocine (Talwin) , propranolol (Inderal), tacrine (Cognex), zileuton (Zyflo), zolmitriptan (Zomig), a me nā mea ʻē aʻe.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 1B1 (CYP1B1) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E loli paha ka hops i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. Lawe i ka hops me kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa e hoʻonui a hoʻemi paha i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau. Ma mua o ka lawe ʻana i nā hop, e kamaʻilio me kāu kauka inā ʻoe e lawe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi o kēia mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi ka theophylline, omeprazole, clozapine, progesterone, lansoprazole, flutamide, oxaliplatin, erlotinib, a me caffeine.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 3A4 (CYP3A4) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. Hiki i nā Hops ke emi i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. Lawe i ka hops me kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa e hoʻonui paha i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau. Ma mua o ka lawe ʻana i nā hop, e kamaʻilio me kāu kauka inā ʻoe e lawe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi o kēia mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi kekahi mau blockers channel calcium (diltiazem, nicardipine, verapamil), nā chemotherapeutic agents (etoposide, paclitaxel, vinblastine, vincristine, vindesine), antifungals (ketoconazole, itraconazole), glucocorticoids (alfentan) , cisapride (Propulsid), fentanyl (Sublimaze), tutupocaine (Xylocaine), losartan (Cozaar), fexofenadine (Allegra), midazolam (Versed), a me nā mea ʻē aʻe.

Nā lāʻau lapaʻau hōʻoluʻolu (depressants CNS)

Hoʻokumu paha ka Hops i ka hiamoe a me ka hiamoe. ʻO nā lāʻau i kumu e hiamoe ai i kapa ʻia ʻo nā mea hōʻohi. Lawe pū i nā hops me nā lāʻau hoʻohiehie hiki ke hiamoe nui.

ʻO kekahi mau lāʻau hoʻohiehie e komo pū me clonazepam (Klonopin), lorazepam (Ativan), phenobarbital (Donnatal), zolpidem (Ambien), a me nā mea ʻē aʻe.

Nā mea kanu a me nā mea hoʻopihapiha me nā mea hoʻohiamoe

Hoʻokumu paha ka Hops i ka hiamoe a me ka hiamoe. Lawe pū i nā hops me nā mea kanu a me nā mea hoʻopili ʻē aʻe i hiki ke loaʻa i kēia hopena ke kumu o ka hiamoe nui. ʻO kekahi o kēia mau mea kanu a me nā mea hoʻopihapiha me 5-HTP, calamus, California poppy, catnip, Jamaican dogwood, kava, St. John's wort, skullcap, valerian, yerba mansa, a me nā mea ʻē aʻe.

ʻAlekohola (Ethanol)

Hiki i ka waiʻona ke hana i ka hiamoe a me ka hiamoe. Hiki paha i ka Hops ke hiamoe a me ka hiamoe. ʻO ka lawe ʻana i ka nui o nā hop a me ka waiʻona paha ka mea e hiamoe nui ai.

Aia ka mahele kūpono o ka hop i nā kumu like ʻole e like me ka makahiki o ka mea hoʻohana, ke olakino, a me nā ʻano ʻē aʻe. I kēia manawa ʻaʻole lawa ka ʻike ʻepekema e hoʻoholo ai i kahi pae kūpono o nā lāʻau no nā hop. E hoʻomanaʻo i ka pono ʻole o ka palekana i nā huahana kūlohelohe a hiki i nā dosages ke koʻikoʻi. E mālama pono i nā ʻōkuhi pili i nā lepili huahana a nīnau i kāu kauka lāʻau a i ʻole kauka a i ʻole ʻoihana olakino ʻē aʻe ma mua o ka hoʻohana ʻana.

ʻO Asperge Sauvage, Hops maʻamau, Couleuvrée, Couleuvrée Septentrionale, Hops ʻEulopa, Hop, Hop Strobile, Hopfenzapfen, Houblon, Humulus lupulus, Lupuli Strobulus, Lupulin, Lúpulo, Pi Jiu Hua, Salsepareille Indigène, Vigne du Nord.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. ʻO Gauruder-Burmester A, Heim S, Patz B, Seibt S. Cucurbita pepo-Rhus aromatica-Humulus lupulus hui e hoʻoliʻiliʻi i nā hōʻailona bladder overactive i nā wahine - kahi aʻo nonintervensal. ʻO Planta Med. 2019; 85: 1044-53. Nānā kiʻi ʻole.
2. Fukuda T, Obara K, Saito J, Umeda S, Ano Y. Nā hopena o nā wai ʻawaʻawa hop, nā mea ʻawaʻawa i ka pia, ma ka ʻike i nā mākua olakino ʻO J Agric Food Chem 2020; 68: 206-12. Nānā kiʻi ʻole.
3. ʻO Luzak B, Kassassir H, Roj E, Stanczyk L, Watala C, Golanski J. Xanthohumol mai nā puʻupuʻu hop (Humulus lupulus L) kaohi i ka ADP-induced platelet reactivity. ʻO Arch Physiol Biochem. 2017 Pepeluali; 123: 54-60. Nānā kiʻi ʻole.
4. Wang S, Dunlap TL, Howell CE, et al. Hop (Humuls lupulus L.) unuhi a me 6-prenylnaringenin e hoʻokomo i ka P450 1A1 catalyzed estrogen 2-hydroxylation. ʻO Chem Res Toxicol. 2016 Jul 18; 29: 1142-50. Nānā kiʻi ʻole.
5. ʻO Scholey A, Benson S, Gibbs A, Perry N, Sarris J, Murray G. Ke ʻimi nei i nā hopena o ka Lactium a me ka zizyphus paʻakikī i ka maikaʻi o ka hiamoe: kahi makapō makapō, kahi hoʻokolokolo i hoʻokolokolo ʻia i hoʻonohonoho ʻia. Nutrients. 2017 Feb 17; 9: E154. Nānā kiʻi ʻole.
6. Chadwick LR, Pauli GF, Farnsworth NR. ʻO ka pharmacognosy o Humulus lupulus L. (hops) me ke koʻikoʻi i nā waiwai estrogenic. Phytomedicine 2006; 13 (1-2): 119-31. Nānā kiʻi ʻole.
7. Maroo N, Hazra A, Das T. Efficacy a me ka palekana o kahi polyherbal sedative-hypnotic formulation NSF-3 i ka hiamoe mua i ka hoʻohālikelike ʻia me zolpidem: kahi hoʻokolohua hoʻomalu kaulike ʻia. ʻO Indian J Pharmacol 2013; 45: 34-9. Nānā kiʻi ʻole.
8. ʻO Hänsel R, Wohlfart R, a me Schmidt H. Ke ʻano sedative-hypnotic o ka hop. 3. Kamailio: nā ʻike o 2-methyl-3-butene-2-ol i nā hop a me nā hoʻomākaukau hop. Planta Med 1982; 45: 224-228.
9. ʻO Shapouri, R a me Rahnema, M. Loiloi i nā hopena antimicrobial o nā hops extract ma intramacrophages Brucella abortus a me B. melitensis. ʻO Jundishapur Pūnaewele o Microbiology 2011; 4 (Hōʻawi 1): S51-S58.
10. Kermanshahi, R. K, Esfahani, B. N, Serkani, J. E, Asghari, G. R, a me Babaie, A. A. P. Ke aʻo ʻana i ka hopena antibacterial o Humulus lupulus ma kekahi o ka Gram positive & Gram maikaʻi bacteria. Ka Nūpepa o nā Mea Pono Lapaʻau 2009; 8: 92-97.
11. Stocker HR. ʻO Sedative und hypnogene Wirkung des Hopfens. Schweizerische Brauerei-Rundschau 1967; 78: 80-89.
12. ʻO Lopez-Jaen, AB, Codoñer-Franch, P, Martínez-Álvarez, JR, Villarino-Marín, A, a me Valls-Bellés, V. Ka hopena i ke olakino o ka pia ʻona ʻole a me ka hop hopment i kahi hui o nā nuns i loko o kahi pani kauoha Nā hana o ka Nānā Nutr 2010; 69 (OCE3): 26.
13. Koetter, U a me Biendl, M. HOPS. HerbalGram 2010;: 44-57.
14. Lee KM, Jung JS, Song DK, a me et al. Nā hopena o Humulus lupulus extract ma ke kikowaena pūnaewele i nāʻiole. Planta Med 1993; 59 (Hōʻawi): A691.
15. Godnic-Cvar, J., Zuskin, E., Mustajbegovic, J., Schachter, E. N., Kanceljak, B., Macan, J., Ilic, Z., a me Ebling, Z. Nā hopena hanu a me nā immunological i nā limahana limahana. 'Am J Ind Med 1999; 35: 68-75. Nānā kiʻi ʻole.
16. Hoʻokomo ʻia ʻo Mannering, G. J. a me Shoeman, J. A. Murine cytochrome P4503A e 2-methyl-3-buten-2-ol, 3-methyl- 1-pentyn-3-ol (meparfynol), a me tert-amyl waiona. Xenobiotica 1996; 26: 487-493. Nānā kiʻi ʻole.
17. Gerhard, U., Linnenbrink, N., Georghiadou, C., a me Hobi, V. Vigilanzmindernde Effekte zweier pflazlicher Schlafmittel (Nā hopena o ʻelua mau mea hiamoe e pili ana i nā mea kanu i ka makaʻala). ʻO Schweiz.Rundsch.Med.Prax. 4-9-1996; 85: 473-481. Nānā kiʻi ʻole.
18. ʻO Mannering, G. J., Shoeman, J. A., a me Shoeman, D. W. Nā hopena o ka colupulone, kahi ʻāpana o ka hop a me ka hū o ka brewers, a me ka chromium ma ka hoʻomanawanui ʻana o ka glucose a me ka cytochrome hepatic P450 i nāʻiole diabetic spontaneous. ʻO Biochem Biophys Res Commun 5-16-1994; 200: 1455-1462. Nānā kiʻi ʻole.
19. ʻO Yasukawa, K., Takeuchi, M., a me Takido, M. Humulon, kahi ʻawaʻawa i ka hop, ke kāohi nei i ka paipai ʻana o ka tumo e 12-O- tetradecanoylphorbol-13-acetate i loko o ka carcinogenesis ʻelua ma ka ʻiole ʻiole. Oncology 1995; 52: 156-158. Nānā kiʻi ʻole.
20. Hansel, R., Wohlfart, R., a me Coper, H. [Nā mea hoʻohui sedative-hypnotic i ka hemo ʻana o ka hop, II]. Z.Naturforsch. [C.] 1980; 35 (11-12): 1096-1097. Nānā kiʻi ʻole.
21. Wohlfart, R., Wurm, G., Hansel, R., a me Schmidt, H. [ʻImi i nā mea hana sedative-hypnotic i hops. 5. Ka hoʻohaʻahaʻa ʻana o nā waikawa ʻawaʻawa i 2-methyl-3-buten-2-ol, kahi mea noho hop me ka hana sedative-hypnotic]. Arch.Pharm. (Weinheim) 1983; 316: 132-137. Nānā kiʻi ʻole.
22. Wohlfart, R., Hansel, R., a me Schmidt, H. [Ka hana sedative-hypnotic o ka hops. 4. Kūkākūkā: ka lāʻau lāʻau o ka hop waiwai 2-methyl-3-buten-2-ol]. Planta Med 1983; 48: 120-123. Nānā kiʻi ʻole.
23. Fenselau, C. a me Talalay, P. Aia paha ka hana oestrogen i ka hop? Meaʻai Meaʻai. Toxicol. 1973; 11: 597-602. Nānā kiʻi ʻole.
24. van Hunsel, F. P. a me Kampschoer, P. [Kahe ʻana o ke koko Postmenopausal a me nā mea hoʻopihapiha dietary: kahi hiki ke pili me ka hoʻomākaukau hop- a me ka soy]. Ned.Tijdschr.Geneeskd. 2012; 156: A5095. Nānā kiʻi ʻole.
25. ʻO Franco, L., Sanchez, C., Bravo, R., Rodriguez, A. B., Barriga, C., Romero, E., a me Cubero, J. Ka hopena sedative o ka pia ʻole ʻona i nā kahu wahine maikaʻi. PLoS.Kekahi. 2012; 7: e37290. Nānā kiʻi ʻole.
26. Kligler, B., Homel, P., Blank, AE, Kenney, J., Levenson, H., a me Merrell, W. Hoʻokolohua kaulike ʻia o ka hopena o kahi lāʻau lapaʻau integrative i ka hoʻokele ʻana i ka hānō i nā mākua e pili ana i ka maʻi. ka maikaʻi o ke ola a me ka hana pulmonary. ʻO Altern .her. ʻO Med Med. 2011; 17: 10-15. Nānā kiʻi ʻole.
27. Jones, JL, Fernandez, ML, McIntosh, MS, Najm, W., Calle, MC, Kalynych, C., Vukich, C., Barona, J., Ackermann, D., Kim, JE, Kumar, V., ʻO Lott, M., Volek, JS, a me Lerman, RH ʻO kahi papaʻai low-glycemic-load-ʻo ke kai Mediterranean e hoʻomaikaʻi ai i nā loli o ka metabolic syndrome i nā wahine, a me ka hoʻohui o kahi meaʻai olakino waiwai waiwai e hoʻonui i nā pono ma ka lipoprotein metabolism. J Clin Lipidol. 2011; 5: 188-196. Nānā kiʻi ʻole.
28. Olas, B., Kolodziejczyk, J., Wachowicz, B., Jedrejek, D., Stochmal, A., a me Oleszek, W. ʻO ka unuhi mai nā hop cones (Humulus lupulus) ma ke ʻano he modulator o ke kaumaha oxidative i nā platelets koko. Pāluna. 2011; 22: 345-352. Nānā kiʻi ʻole.
29. Di, Viesti, V, Carnevale, G., Zavatti, M., Benelli, A., a me Zanoli, P. Hoʻonui i ka hoʻonāukiuki moekolohe i nā ʻiole wahine i mālama ʻia me Humulus lupulus L. extract. ʻO J Ethnopharmacol. 3-24-2011; 134: 514-517. Nānā kiʻi ʻole.
30. Choi, Y., Jermihov, K., Nam, SJ, Sturdy, M., Maloney, K., Qiu, X., Chadwick, LR, Main, M., Chen, SN, Mesecar, AD, Farnsworth, NR, Pauli, GF, Fenical, W., Pezzuto, JM, a me van Breemen, RB Nānā i nā huahana kūlohelohe no nā mea pāpā i ka quinone reductase-2 e hoʻohana ana i ka ultrafiltration LC-MS. Anal. ʻOihana 2-1-2011; 83: 1048-1052. Nānā kiʻi ʻole.
31. ʻO Lerman, RH, Minich, DM, Darland, G., Lamb, JJ, Chang, JL, Hsi, A., Bland, JS, a me Tripp, ML Nā kumuhana me ka LDL kolesterol kiʻekiʻe a me nā maʻi maʻi metabolic e pono ai mai ka hoʻopili ʻia me ka protein soy, nā phytosterols , hops rho iso-alpha acid, a me Acacia nilotica proanthocyanidins. J Clin Lipidol. 2010; 4: 59-68. Nānā kiʻi ʻole.
32. Lee, IS, Lim, J., Gal, J., Kang, JC, Kim, HJ, Kang, BY, a me Choi, HJ ʻO ka hana anti-inflammatory o xanthohumol e pili ana i ka heme oxygenase-1 hoʻokomo ma o NRF2-ARE hōʻailona i ka microglial BV2 nā pūnaewele. Neurochem .nt 2011; 58: 153-160. Nānā kiʻi ʻole.
33. Deeb, D., Gao, X., Jiang, H., Arbab, A. S., Dulchavsky, S. A., a me Gautam, S. C. ʻO ka ulu ʻana o ka hopena a me nā hopena apoptosis e hoʻouluulu nei i ka xanthohumol, kahi chalone prenylated i loaʻa i hops, i loko o nā cell cancer prostate. Anticancer Res 2010; 30: 3333-3339. Nānā kiʻi ʻole.
34. ʻO Negrao, R., Costa, R., Duarte, D., Taveira, Gomes T., Mendanha, M., Moura, L., Vasques, L., Azevedo, I., a me Soares, R. Angiogenesis a me ka hōʻailona hōʻailona. he pahuhopu nā pia polyphenols ma nā hunaola vascular. ʻO J Cell Biochem 12-1-2010; 111: 1270-1279. Nānā kiʻi ʻole.
35. ʻO Minich, DM, Lerman, RH, Darland, G., Babish, JG, Pacioretty, LM, Bland, JS, a me Tripp, ML Hop a me Acacia Phytochemicals i hoʻemi i ka Lipotoxicity ma 3T3-L1 Adipocytes, db / db Mice, a me nā mea me ka Metabolic Syndrome. J Nutr Metab 2010; 2010 Nānā i ka abstract.
36. ʻO Salter, S. a me Brownie, S. Ke mālama nei i ka hiamoe mua - ka hopena o valerian a me nā hop. Aust. ʻOhana. Kauka 2010; 39: 433-437. Nānā kiʻi ʻole.
37. Cornu, C., Remontet, L., Noel-Baron, F., Nicolas, A., Feugier-Favier, N., Roy, P., Claustrat, B., Saadatian-Elahi, M., a me Kassai, B . ʻO kahi mea hoʻopiha papaʻai e hoʻomaikaʻi ai i ka maikaʻi o ka hiamoe: kahi hoʻokolohua hoʻokolohua hoʻokolohua kaulike ʻia. BMC. Hoʻohui Altern Med 2010; 10: 29. Nānā kiʻi ʻole.
38. Bolca, S., Li, J., Nikolic, D., Roche, N., Blondeel, P., Possemiers, S., De, Keukeleire D., Bracke, M., Heyerick, A., van Breemen, RB , a me Depypere, H. Hoʻolilo i nā hop prenylflavonoids i kaʻiʻo umauma kanaka. Mol Nutr Food Res 2010; 54 Hōʻuluʻulu 2: S284-S294. Nānā kiʻi ʻole.
39. Radovic, B., Hussong, R., Gerhauser, C., Meinl, W., Frank, N., Becker, H., a me Kohrle, J. Xanthohumol, he chalcone prenylated mai hops, hoʻololi i ka hōʻike hepatic o nā genes i komo i loko. ka hoʻolaʻa ʻana o ka hormone thyroid a me ka metabolism. Mol Nutr Food Res 2010; 54 Hōʻuluʻulu 2: S225-S235. Nānā kiʻi ʻole.
40. Philips, N., Samuel, M., Arena, R., Chen, YJ, Conte, J., Natarajan, P., Haas, G., a me Gonzalez, S. Direct inhibition o elastase a me matrixmetalloproteinases a me ka stimulate o biosynthesis o nā collagens fibrillar, elastin, a me nā fibrillins e xanthohumol. ʻO J Cosmet.Sci 2010; 61: 125-132. Nānā kiʻi ʻole.
41. Strathmann, J., Klimo, K., Sauer, S. W., Okun, J. G., Prehn, J. H., a me Gerhauser, C. Xanthohumol i hoʻokomo ʻia i kahi manawa superoxide anion radical formation e hoʻoulu i nā hunaola maʻi maʻi i loko o apoptosis ma o ka mitochondria-mediated mechanical. FASEB J 2010; 24: 2938-2950. Nānā kiʻi ʻole.
42. ʻO Peluso, MR, Miranda, CL, Hobbs, DJ, Proteau, RR, a me Stevens, JF Xanthohumol a me nā flavonoids prenylated pili e kāohi i ka hana cytokine inflammatory i loko o ka LPS-THP-1 monocytes i hoʻopili ʻia: nā pilina pili i ka hana a me ka silico paʻa ʻana i ka protein like ʻole myeloid -2 (MD-2). Planta Med 2010; 76: 1536-1543. Nānā kiʻi ʻole.
43. Erkkola, R., Vervarcke, S., Vansteelandt, S., Rompotti, P., De, Keukeleire D., a me Heyerick, A. A randomized, double-blind, placebo-ruled, cross-over pilot study on the use o kahi huahana hop standardized e hoʻoliʻiliʻi i nā discomforts menopausal. Phytomedicine. 2010; 17: 389-396. Nānā kiʻi ʻole.
44. Chiummariello, S., De, Gado F., Monarca, C., Ruggiero, M., Carlesimo, B., Scuderi, N., a me Alfano, C. [Multicentric study on a topical compound with lymph-draining action in the ka mālama ʻana i ka ulcer phlebostatic o nā ʻāpana haʻahaʻa]. G.Chir 2009; 30 (11-12): 497-501. Nānā kiʻi ʻole.
45. ʻO Dorn, C., Kraus, B., Motyl, M., Weiss, TS, Gehrig, M., Scholmerich, J., Heilmann, J., a me Hellerbrand, C. Xanthohumol, kahi chalcon i loaʻa mai nā hops, kāohi i ka mumū hepatic. a me fibrosis. Mol Nutr Food Res 2010; 54 Hōʻuluʻulu 2: S205-S213. Nānā kiʻi ʻole.
46. ʻO Dorn, C., Weiss, T. S., Heilmann, J., a me Hellerbrand, C. Xanthohumol, kahi chalcone prenylated i loaʻa mai nā hops, kāohi i ka hoʻonui ʻana, ka neʻe ʻana a me ka interleukin-8 expression o nā cell carcinoma hepatocellular. Int J Oncol. 2010; 36: 435-441. Nānā kiʻi ʻole.
47. Hartkorn, A., Hoffmann, F., Ajamieh, H., Vogel, S., Heilmann, J., Gerbes, AL, Vollmar, AM, a me Zahler, S. Nā hopena Antioxidant o xanthohumol a me ka hopena hana ma ka hepatic ischemia-reperfusion ʻeha. ʻO J Nat Prod 2009; 72: 1741-1747. Nānā kiʻi ʻole.
48. Zhang, N., Liu, Z., Han, Q., Chen, J., a me Lv, Y. Xanthohumol e hoʻonui i ka hopena antiviral o interferon alpha-2b e kūʻē i ka maʻi diarrhea viral bovine, kahi pani o ka maʻi hepatitis C. Phytomedicine. 2010; 17: 310-316. Nānā kiʻi ʻole.
49. Dumas, ER, Michaud, AE, Bergeron, C., Lafrance, JL, Mortillo, S., a me Gafner, S. Nā hopena Deodorant o kahi hua hop hop supercritical: ka hana antibacterial e kūʻē iā Corynebacterium xerosis a me Staphylococcus epidermidis a me ka hoʻāʻo ʻana o ka hops / kiniki ricinoleate koʻokoʻo i loko o nā kānaka ma o ka sensory loiloi o ka axillary deodorancy. ʻO J Cosmet. Dermatol 2009; 8: 197-204. Nānā kiʻi ʻole.
50. Caballero, I., Agut, M., Armentia, A., a me Blanco, C. A. Ka mea nui o nā tetrahydroiso alpha-acid i ke kūpaʻa microbiological o ka pia. J AOAC Int 2009; 92: 1160-1164. Nānā kiʻi ʻole.
51. ʻO Konda, V. R., Desai, A., Darland, G., Bland, J. S., a me Tripp, M. L. Rho iso-alpha acid mai nā hops e kāohi i ke ala GSK-3 / NF-kappaB a hoʻemi i nā kaha kuni e pili ana i ka iwi a me ka cartilage degradation. ʻO J Inflamm. (Lond) 2009; 6:26. Nānā kiʻi ʻole.
52. Van, Cleemput M., Heyerick, A., Libert, C., Swerts, K., Philippe, J., De, Keukeleire D., Haegeman, G., a me De, Bosscher K. Hop nā awaawaʻawaʻawa e pale pono i ka mumuna kūʻokoʻa. o GRalpha, PPARalpha, a i ʻole PPARgamma. ʻO Mol Nutr Food Res 2009; 53: 1143-1155. Nānā kiʻi ʻole.
53. ʻO Lupinacci, E., Meijerink, J., Vincken, JP, Gabriele, B., Gruppen, H., a me Witkamp, ​​RF Xanthohumol mai hop (Humulus lupulus L.) kahi mea kāohi pono i ka monocyte chemoattractant protein-1 a me ka tumor nekrosis hoʻokuʻu hoʻokuʻu factor-alpha i ka LPS-stimulated RAW 264.7 mouse macrophages a me U937 monotaga kanaka. ʻO J Agric Food Chem 8-26-2009; 57: 7274-7281. Nānā kiʻi ʻole.
54. ʻO Ross, S. M. ʻO nā maʻi hiamoe: ʻike ʻia kahi lawelawe mahele lāʻau hoʻokahi o valerian / hops fluid extract (dormeasan) i ka hoʻomaikaʻi ʻana i ka hiamoe. Holist. Nā Hana Hana 2009; 23: 253-256. Nānā kiʻi ʻole.
55. Zanoli, P., Zavatti, M., Rivasi, M., Benelli, A., Avallone, R., a me Baraldi, M. Nā hōʻike hoʻokolohua o ka hana anaphrodisiac o Humulus lupulus L. i nāʻiole kāne naive. ʻO J Ethnopharmacol. 8-17-2009; 125: 36-40. Nānā kiʻi ʻole.
56. ʻO Gao, X., Deeb, D., Liu, Y., Gautam, S., Dulchavsky, SA, a me Gautam, SC Immunomodulatory ʻoihana o xanthohumol: kaohi ʻana i ka hoʻonui ʻana o ka pūnaewele T, ka cytotoxicity waena waena a me ka hana cytokine Th1 ma o ka kaohi ʻana o NF-kappaB. Immunopharmacol.Immunotoxicol. 2009; 31: 477-484. Nānā kiʻi ʻole.
57. ʻO Chung, W. G., Miranda, C. L., Stevens, J. F., a me Maier, C. S. Hop proanthocyanidins e hoʻohuli i ka apoptosis, protein carbononyony, a me ka cytoskeleton disorganization i loko o nā cellenal adenocarcinoma cellectal kanaka ma o ka reactive oxygen species. Meaʻai Chem Toxicol. 2009; 47: 827-836. Nānā kiʻi ʻole.
58. Yamaguchi, N., Satoh-Yamaguchi, K., a me Ono, M. ʻO ka loiloi in vitro o ka antibacterial, anticollagenase, a me nā hana antioxidant o nā mea hop (Humulus lupulus) e kamaʻilio ana i nā huehue vulgaris. Phytomedicine. 2009; 16: 369-376. Nānā kiʻi ʻole.
59. Hall, A. J., Babish, J. G., Darland, G. K., Carroll, B. J., Konda, V. R., Lerman, R. H., Bland, J. S., a me Tripp, M. L. Palekana, ka pono a me ka hana anti-inflammatory o rho iso-alpha-acid mai nā hop. Phytochemistry 2008; 69: 1534-1547. Nānā kiʻi ʻole.
60. Schiller, H., Forster, A., Vonhoff, C., Hegger, M., Biller, A., a me Winterhoff, H. Nā hopena sedating o Humulus lupulus L. extracts. Phytomedicine. 2006; 13: 535-541. Nānā kiʻi ʻole.
61. Morali, G., Polatti, F., Metelitsa, EN, Mascarucci, P., Magnani, P., a me Marre, GB Open, nā noiʻi lapaʻau ʻole hoʻomalu ʻia e loiloi i ka pono a me ka palekana o kahi mea olakino ma ke ʻano he gel. a hoʻohana intravaginally i nā wahine postmenopausal me ka atrophy genital. Arzneimittelforschung 2006; 56: 230-238. Nānā kiʻi ʻole.
62. Heyerick, A., Vervarcke, S., Depypere, H., Bracke, M., a me De Keukeleire, D. A prospective mua, randomized, pālua makapō, placebo-kaohi hoʻopaʻa haʻawina e pili ana i ka hoʻohana ʻana o ka hae hae hae e hoʻoliʻiliʻi. hoʻoliʻiliʻi menopausal. Maturitas 5-20-2006; 54: 164-175. Nānā kiʻi ʻole.
63. Chadwick, LR, Nikolic, D., Burdette, JE, Overk, CR, Bolton, JL, van Breemen, RB, Frohlich, R., Fong, HH, Farnsworth, NR, a me Pauli, GF Estrogens a me nā congeners mai nā hop hop ( Humulus lupulus). J Nat.Prod. 2004; 67: 2024-2032. Nānā kiʻi ʻole.
64. Skorska, C., Mackiewicz, B., Gora, A., Golec, M., a me Dutkiewicz, J. Nā hopena olakino o ka hopena inhalation i ka lepo lepo i nā mahiʻai hop. Ann. Univ Mariae.Curie Sklodowska [Med] 2003; 58: 459-465. Nānā kiʻi ʻole.
65. ʻO Gora, A., Skorska, C., Sitkowska, J., Prazmo, Z., Krysinska-Traczyk, E., Urbanowicz, B., a me Dutkiewicz, J. Hōʻike ʻana i nā mea ulu hop i nā bioaerosols. Ann.Agric.En environment.Med 2004; 11: 129-138. Nānā kiʻi ʻole.
66. Yajima, H., Ikeshima, E., Shiraki, M., Kanaya, T., Fujiwara, D., Odai, H., Tsuboyama-Kasaoka, N., Ezaki, O., Oikawa, S., a me Kondo, K. Isohumulones, nā waikawa ʻawa i lawe ʻia mai hops, e hoʻoulu i nā alpha receptor activated activated peroxisome alpha a me gamma a hoʻemi i ke kūpaʻa o ka insulin ʻO J Biol Chem 8-6-2004; 279: 33456-33462. Nānā kiʻi ʻole.
67. Simpson, W. J. a me Smith, A. R. Nā mea e hoʻopili ana i ka hana antibacterial o nā hop hop a me kā lākou mea i loaʻa. ʻO J Appl Bacteriol. 1992; 72: 327-334. Nānā kiʻi ʻole.
68. Langezaal, C. R., Chandra, A., a me Scheffer, J. J. Antimicrobial kānana o nā pono aila a me nā extracts o kekahi Humulus lupulus L. mahiʻai. ʻO Pharm Weekbl Sci 12-11-1992; 14: 353-356. Nānā kiʻi ʻole.
69. ʻO Stevens, J. F., Miranda, C. L., Frei, B., a me Buhler, D. R. Ka pāpā ʻana i ka oxidation LDL i hoʻopili ʻia e ka peroxynitrite e nā flavonoid prenylated: ʻo ka alpha, beta-unsaturated keto functionality o 2'-hydroxychalcones ma ke ʻano he antioxidant pharmacophore. ʻO Chem Res Toxicol 2003; 16: 1277-1286. Nānā kiʻi ʻole.
70. ʻO Mannering, G. J., Shoeman, J. A., a me Deloria, L. B. ʻIʻike ʻia o ka meaola hops antibiotic, colupulone, ma ke ʻano he mea hoʻokumu i ka cytochrome hepatic P-4503A i kaʻiole. Ka Waihona Metab Lapaʻau 1992; 20: 142-147. Nānā kiʻi ʻole.
71. ʻO Miranda, CL, Yang, YH, Henderson, MC, Stevens, JF, Santana-Rios, G., Deinzer, ML, a me Buhler, DR Prenylflavonoids mai nā hops e kāohi i ka hoʻoweliweli metabolic o ka carcinogenic heterocyclic amine 2-amino-3-methylimidazo [4, 5- f] quinoline, uwao ʻia e cDNA-i hōʻike ʻia CYP1A2 kanaka. Nānā Metab Dispos 2000; 28: 1297-1302. Nānā kiʻi ʻole.
72. Hoʻomaha ʻo Sun J. Kakahiaka / ahiahi i ke ʻano hoʻopāpā menopausal i nā hōʻailona menopausal: kahi aʻo pailaka. J Altern Complement Med 2003; 9: 403-9. Nānā kiʻi ʻole.
73. ʻO Swanston-Flatt, S. K., Lā, C., Flatt, P. R., Gould, B. J., a me Bailey, C. J. Nā hopena Glycemic o ka mālama ʻana i nā mea kanu ʻEulopa maʻamau no ka maʻi kō. ʻO nā noiʻi i nā ʻiole diabetic maʻamau a me ka streptozotocin. Diabetes Res 1989; 10: 69-73. Nānā kiʻi ʻole.
74. Shou, C., Li, J., a me Liu, Z. Kākoʻo a me nā lāʻau ʻē aʻe i ka mālama ʻana i nā hōʻailona menopausal. Chin J Integr Med 2011; 17: 883-888. Nānā kiʻi ʻole.
75. Holick, MF, Lamb, JJ, Lerman, RH, Konda, VR, Darland, G., Minich, DM, Desai, A., Chen, TC, Austin, M., Kornberg, J., Chang, JL, Hsi, A., Bland, JS, a me Tripp, ML Hop rho iso-alpha acid, berberine, wikamina D3 a me ka wikamina K1 e hoʻopili maikaʻi i nā biomarkers o ka hoʻohuli iwi i nā wahine postmenopausal i ka 14 mau pule. ʻO J Bone Miner. Metab 2010; 28: 342-350. Nānā kiʻi ʻole.
76. ʻO Possemiers, S., Bolca, S., Grootaert, C., Heyerick, A., Decroos, K., Dhooge, W., De, Keukeleire D., Rabot, S., Verstraete, W., a me Van de Wiele , T. ʻO ka prenylflavonoid isoxanthohumol mai hops (Humulus lupulus L.) e hoʻoulu ʻia i loko o ka pottoestrogen 8-prenylnaringenin i vitro a me ka ʻōpū o ke kanaka. ʻO J Nutr 2006; 136: 1862-1867. Nānā kiʻi ʻole.
77. Stevens, J. F. a me ʻAoʻao, J. E. Xanthohumol a me nā prenylflavonoids e pili ana mai nā hop a me ka pia: i kou olakino maikaʻi! Phytochemistry 2004; 65: 1317-1330. Nānā kiʻi ʻole.
78. Nā pule hebedoma, B. S. Formulated o nā mea hoʻopihapihaʻai a me nā mea kanu lāʻau no ka hoʻomaha a me ka hana anxiolytic: Relarian. ʻO Med Sci Monit. 2009; 15: RA256-RA262. Nānā kiʻi ʻole.
79. Müller-Limmroth W, Ehrenstein W. [ʻO nā hoʻokolohua hoʻokolohua o nā hopena o Seda-Kneipp i ka hiamoe o ka hiamoe i hoʻopilikia ʻia i nā kumuhana; nā hopena no ka mālama ʻana i nā haunaele hiamoe like ʻole (unuhi a ka mea kākau)]. ʻO Med Klin. 1977 Jun 24; 72: 1119-25. Nānā kiʻi ʻole.
80. Schmitz M, Jäckel M. [Ke aʻo hoʻohālikelike no ka loiloi i ka maikaʻi o ke ola o nā mea maʻi me nā maʻi hiamoe exogenous (hoʻomaka ka hiamoe manawa ʻole a me nā maʻi hōʻoki moe) mālama ʻia me kahi hoʻomākaukau hops-valarian a me ka lāʻau benzodiazepine ʻO Wien Med Wochenschr. 1998; 148: 291-8. Nānā kiʻi ʻole.
81. Lukaczer D, Darland G, Tripp M, et al. ʻO kahi hoʻokolohua hoʻokolohua e loiloi ana iā Meta050, kahi hui pilikino o nā iso-alpha acid i hoʻemi ʻia, ka rosemary extract a me nā waikawa oleanolic i nā mea maʻi me ka arthritis a me ka fibromyalgia. Phytother Res 2005; 19: 864-9. Nānā kiʻi ʻole.
82. Morin CM, Koetter U, Bastien C, et al. Hoʻohui ʻia ʻo Valerian-hops a me diphenhydramine no ka mālama ʻana i ka hiamoe: kahi hoʻokolohua hoʻokolohua hoʻokolohua hoʻokolohua placebo. Hiamoe 2005; 28: 1465-71. Nānā kiʻi ʻole.
83. Colgate EC, Miranda CL, Stevens JF, et al. ʻO Xanthohumol, kahi prenylflavonoid i loaʻa mai nā hops e hoʻokomo i ka apoptosis a kāohi i ka hoʻouluulu NF-kappaB i nā hunaola epithelial prostate. ʻO Lett Lett 2007; 246: 201-9. Nānā kiʻi ʻole.
84. ʻO Monteiro R, Becker H, Azevedo I, Calhau C. Ka hopena o ka hop (Humulus lupulus L.) flavonoids ma ka hana aromatase (estrogen synthase). ʻO Agric Food Chem 2006; 54: 2938-43. Nānā kiʻi ʻole.
85. ʻO Nozawa H. Xanthohumol, ka chalcone mai ka pia hops (Humulus lupulus L.), ʻo ia ka ligand no ka reseptor X farnesoid a hoʻonui i ka lipid a me ka metabolism glucose i nāʻiole KK-A (y). ʻO Biochem Biophys Res Commun 2005; 336: 754-61. Nānā kiʻi ʻole.
86. Overk CR, Yao P, Chadwick LR, et al. Hoʻohālikelike o nā hana in vitro estrogenic o nā hui mai hops (Humulus lupulus) a me ka ʻulaʻula (Trifolium pratense). ʻO J Agric Food Chem 2005; 53: 6246-53. Nānā kiʻi ʻole.
87. Henderson MC, Miranda CL, Stevens JF, et al. ʻO ka in vitro inhibition o nā kānaka énoma P450 e nā flavonoid prenylated mai hops, Humulus lupulus. Xenobiotica 2000; 30: 235-51 .. Nānā i ka abstract.
88. Milligan SR, Kalita JC, Pocock V, et al. ʻO nā hana endocrine o 8-prenylnaringenin a me nā hop (Humulus lupulus L.) flavonoids e pili ana. J Clin Endocrinol Metab 2000; 85: 4912-5 .. Nānā i ka abstract.
89. Milligan SR, Kalita JC, Heyerick A, et al. Ka hoʻomaopopo ʻana i kahi phytoestrogen ikaika i hops (Humulus lupulus L.) a me ka pia. J Clin Endocrinol Metab 1999; 84: 2249-52 .. Nānā i ka abstract.
90. Miranda CL, Stevens JF, Helmrich A, et al. Nā hopena antiproliferative a me ka cytotoxic o flavonoids prenylated mai hops (Humulus lupulus) i nā lālani maʻi ʻaʻai kanaka. Nā Mea Hana Meaola Toxicol 1999; 37: 271-85 .. Nānā i ka abstract.
91. Liu J, Burdette JE, Xu H, et al. ʻO ka loiloi ʻana i ka hana estrogenic o nā mea kanu nā mea kanu no ka mālama kūpono ʻana i nā hōʻailona menopausal. ʻO J Agric Food Chem 2001; 49: 2472-9 .. Nānā i ka abstract.
92. ʻO Dixon-Shanies D, ʻo Shaikh N. Ka ulu ʻana o nā hunaola maʻi umauma kanaka e nā mea kanu a me nā phytoestrogens. Oncol Rep 1999; 6: 1383-7 .. Nānā i ka abstract.
93. ʻO Leathwood PD, Chauffard F, Heck E, Munoz-Box R. Hoʻonui ʻia ke aʻa o valerian root (Valeriana officinalis L.) i ka maikaʻi o ka hiamoe o ke kāne. ʻO Pharmacol Biochem Behav 1982; 17: 65-71. Nānā kiʻi ʻole.
94. ʻO Eagon PK, Elm MS, Hunter DS, et al. Nā lāʻau lapaʻau: nā hoʻololi o ka hana estrogen. Era o Hope Mtg, Dept Defence; Breast Cancer Res Prog, Atlanta, GA 2000; Jun 8-11.
95. Palapala ʻElele o nā Rula Pekelala. Kahi inoa 21. Mahele 182 - Hoʻomaopopo ʻia nā mea maʻamau he palekana. Loaʻa ma: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
96. Zava DT, Dollbaum CM, Blen M. Estrogen a me ka progestin bioactivity o nā meaʻai, nā mea kanu, a me nā mea ʻala. Proc Soc Exp Biol Med 1998; 217: 369-78. Nānā kiʻi ʻole.
97. ʻO Brinker F. Herb Contraindications a me nā launa lāʻau. ʻElua ed. Sandy, OR: Nā Papa Hana Lapaʻau Eclectic, 1998.
98. McGuffin M, Hobbs C, Upton R, Goldberg A, huaʻōlelo. ʻO ka puke lima palekana palekana botanical ʻAmelika Hui Pū ʻIa ʻAmelika. ʻO Boca Raton, FL: CRC Press, LLC 1997.
99. Newall CA, Anderson LA, Philpson JD. Laau Lapaʻau: He alakaʻi no nā ʻoihana mālama ola. Ladana, UK: Ka Hale Paʻi Lapaʻau, 1996.

Nānā hope - 01/05/2021